Editor’s Note: In an article recently published in Harvard Business Review, James Rebitzer and Robert Rebitzer—coauthors of the new book Why Not Better and Cheaper? Healthcare and Innovation—discuss the challenges the U.S. health care sector faces that could slow the adoption of artificial intelligence (AI). Summarized below, the article also shares three keys to accelerating adoption by […]
Generative artificial-intelligence chatbots like ChatGPT are known to get things wrong sometimes, a process known as “hallucinating.” But can anyone be held liable if those incorrect responses are damaging in some way? Host Zoe Thomas talks to a legal expert and an AI ethicist to explore the legal landscape for generative AI technology, and the […]
Biometric Surveillance Is Quietly Expanding: Bright- Line Rules Are Key AI Now Institute Despite mounting evidence of harm and untested scientific claims, biometric systems are still quietly proliferating and embedding themselves in new domains like cars and the metaverse. Existing policy approaches based on data protection law, like the GDPR, have proven to be ineffective […]
Rick Gannotta (professor in the MS in Health Law and Strategy program) and Dr Arthur Caplan discuss bioethics and its implications within emerging technologies, the current fascination with aging and the medical industries response to meeting that demand, sources of truth in policy and politics, the ethical risk of algorithms, AI dependency & addiction as […]
Moderna is suing Pfizer and BioNTech, claiming that the companies’ COVID-19 vaccine infringes on Moderna’s patents. The COVID-19 vaccines from Moderna and Pfizer-BioNTech both use messenger RNA (mRNA) and are the only two vaccines approved in the US to do so.
WASHINGTON, DC — The Comptroller General of the United States, Gene L. Dodaro, who serves as the head of the U.S. Government Accountability Office (GAO), has announced the appointment of six new members of the Patient-Centered Outcomes Research Institute’s (PCORI) Board of Governors.
Bill Bernstein, leader of Manatt Health, told Fierce Healthcare in an interview that there is a “thirst” in healthcare for midcareer education. For example, physicians rising through the ranks into leadership roles come armed with a bounty of clinical knowledge but may need additional training on more administrative topics.
The health field – including healthcare delivery, technology, pharmacology, and social factors affecting health – is experiencing disruptive change. There’s never been more demand for dynamic leaders who have the training and perspective to make strategic decisions that promote quality, performance, growth, and innovation.
New York University is announcing the establishment of an MS in Health Law and Strategy (MS HLS) for experienced professionals from a broad range of health-related fields and backgrounds. Offered jointly by NYU School of Law and NYU Wagner Graduate School of Public Service, the one-year program will provide the training and perspective to prepare […]
Christopher Boone, PhD AbbVie, VP, Global Head, Health Economics & Outcomes Research Patient-Centered Outcomes Research Institute (PCORI) Board Member When the inaugural class in the Master of Science in Health Law and Strategy arrives at the program’s final semester, industry and policy veteran Christopher Boone will be one of the professors leading them through the […]
